Lunai Bioworks Inc. Other Non-Current Assets
Lunai Bioworks Inc. (LNAI) had Other Non-Current Assets of $6.11 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-05-15
- 2026-03-31: Other Assets, Noncurrent $6.11M.
- 2025-12-31: Other Assets, Noncurrent $6.14M.
- 2025-09-30: Other Assets, Noncurrent $6.15M.
- 2025-06-30: Other Assets, Noncurrent $6.82M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-03-31 | $6.11M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $6.14M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $6.15M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $6.82M 10-Q · filed 2026-05-15 | |
| 2025-03-31 | $113.66M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $109.21M 10-Q · filed 2025-02-19 | |
| 2024-09-30 | $119.43M 10-Q/A · filed 2025-02-19 | |
| 2024-06-30 | $160.65M 10-K · filed 2025-09-29 | |
| 2024-03-31 | $176.38M 10-Q/A · filed 2025-02-19 | $210.57M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $55.12M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $55.17M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $55.23M 10-Q/A · filed 2025-02-19 | |
| 2023-03-31 | $74.27M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $74.33M 10-Q · filed 2023-03-09 | |
| 2022-09-30 | $74.38M 10-Q · filed 2023-03-07 | |
| 2022-06-30 | $74.48M 10-K · filed 2023-10-02 | |
| 2022-03-31 | $167.76M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $167.85M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $167.91M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $167.99M 10-K · filed 2023-02-27 | |
| 2020-06-30 | $168.38M 10-K · filed 2021-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |